Trial Profile
A trial of bevacizumab in patients with metastatic colorectal cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Dec 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Biomarker; Pharmacodynamics
- 18 Dec 2015 New trial record